Extracellular vesicles in meningioma patients
Part of Brain & nervous system, Cancer clinical trials.
This study is looking at tiny particles called extracellular vesicles in the blood of people with meningioma, a type of brain tumor. The goal is to learn more about these particles and how they relate to the tumor, which may help in understanding the disease better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed meningioma (either by biopsy or imaging like MRI or DOTATOC-PET CT).
- Your tumor must be visible on an MRI scan.
- You must be scheduled to receive radiation therapy (radiotherapy).
- You must be at least 18 years old.
- You must have a Karnofsky Performance Score of 60% or higher (meaning you can care for most of your own needs).
- If you are a woman who can have children, you must use adequate contraception.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for tumor cells in your blood or spinal fluid to see if they can help track aggressive meningiomas that have come back. It may help doctors understand your cancer better and guide future treatments.
This trial studies whether a procedure that blocks the tumor’s blood supply (embolization) can help people with a typical meningioma that is growing or causing symptoms. It may help shrink or control the tumor by cutting off its main blood supply.
This trial tests a new type of MRI scan that may help see meningioma brain tumors more clearly. It is a short imaging study for people who plan to have surgery or monitoring.
This study looks at how your tumor's genes, personal health habits, and other factors affect your long-term health after a meningioma diagnosis. You'll be asked to complete surveys about your health and experiences—no new treatments or procedures are involved.
This trial tests whether a higher dose of proton therapy, a precise type of radiation, can better control a rare and more aggressive form of meningioma brain tumor. It aims to improve outcomes for patients who have had surgery and need radiation.
This Phase 2 trial studies cabozantinib, a targeted pill medicine, for meningioma that has come back or is getting worse after standard treatment like surgery or radiation. It aims to shrink tumors and slow progression when other options may have limited benefit.
Hear when a new Meningioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.